The Estonian Competition Authority analyses the competition situation in the pharma sector in order to assess the medicine pricing regulation

The price regulation of pharmaceuticals is illusory* The Competition Authority conducted an analysis of the competition situation in order to assess the functioning of the regulation that sets the limits for the prices of medicines. The Competition Authority

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Estonian Competition Authority, The Estonian Competition Authority analyses the competition situation in the pharma sector in order to assess the medicine pricing regulation, 2 September 2020, e-Competitions September 2020, Art. N° 97064

Visites 44

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues